Copyright
©The Author(s) 2024.
World J Gastroenterol. May 7, 2024; 30(17): 2354-2368
Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2354
Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2354
Overall eradication rate % (95%CI) | Eradication rate for first-treatment patients % (95%CI) | Eradication rate for retreatment patients % (95%CI) | ||||
Intention-to-treat analysis | Per-protocol analysis | Intention-to-treat analysis | Per-protocol analysis | Intention-to-treat analysis | Per-protocol analysis | |
Minocycline-containing regimen | 82.3% (79.7%-85.1%) | 90.0% (87.7%-92.4%) | 83.6% (80.6%-86.7%) | 90.5% (88.7%-92.3%) | 82.3% (79.5%-85.2%) | 90.8% (86.4%-95.4%) |
Minocycline-containing combination regimen with nitroimidazole antibiotics | 82.1% (77.9%-86.5%) | 89.5% (86.0%-93.0%) | 82.4% (77.9%-87.0%) | 89.4% (86.9%-91.9%) | 85.4% (81.0%-90.0%) | 80.2% (56.8%-100.0%) |
Minocycline-containing combination regimen with amoxicillin | 83.8% (81.9%-85.9%) | 89.9% (86.3%-93.6%) | 85.9% (83.0%-89.0%) | 92.7% (90.4%-95.1%) | 82.7% (80.0%-85.5%) | 90.9% (85.9%-96.1%) |
- Citation: Zhou K, Li CL, Zhang H, Suo BJ, Zhang YX, Ren XL, Wang YX, Mi CM, Ma LL, Zhou LY, Tian XL, Song ZQ. Minocycline in the eradication of Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(17): 2354-2368
- URL: https://www.wjgnet.com/1007-9327/full/v30/i17/2354.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i17.2354